empe May 14, 2026 Rapid Detection of M. tuberculosis and Its Resistance to Rifampicin and Isoniazid with the mfloDx™ MDR‑TB test Background: Rapid detection of tuberculosis (TB) and its resistance are essential for the prompt initiation… Read More
empe May 14, 2026 Tuberculosis Diagnostics Pipeline Report 2025 Tuberculosis (TB) is the leading cause of death from an infectious disease worldwide, claiming an… Read More
empe May 13, 2026 Novel diagnostic test for the detection of Mycobacterium tuberculosis and its resistance to rifampicin, isoniazid, and fluoroquinolones directly in sputum samples Introduction: Rapid identification of tuberculosis (TB) and its drug resistance is crucial for starting effective… Read More
empe May 13, 2026 WHO Global TB Report 2023 New diagnosticsThe diagnostic pipeline has expanded considerably in terms of the number of tests, products… Read More
empe September 17, 2025 Decoding India’s TB Landscape: Market Size and Future Trend Tuberculosis (TB) continues to cast a long shadow over India’s public health landscape. As the… Read More
empe September 17, 2025 A Deep Dive into TB Treatments in India: Current Practices and Future Directions Tuberculosis (TB) treatment in India is a complex and evolving field. With the emergence of… Read More
empe September 16, 2025 Unveiling the Potential: Opportunities in India TB Market The fight against tuberculosis (TB) in India is not just about combating a disease; it’s… Read More